Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Current therapies for Morquio A syndrome and their clinical outcomes.

Sawamoto K, Suzuki Y, Mackenzie WG, Theroux MC, Pizarro C, Yabe H, Orii KE, Mason RW, Orii T, Tomatsu S.

Expert Opin Orphan Drugs. 2016;4(9):941-951. doi: 10.1080/21678707.2016.1214572. Epub 2016 Jul 28.

2.

Mucopolysaccharidosis IVA and glycosaminoglycans.

Khan S, Alméciga-Díaz CJ, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, Mason RW, Orii T, Tomatsu S.

Mol Genet Metab. 2017 Jan - Feb;120(1-2):78-95. doi: 10.1016/j.ymgme.2016.11.007. Epub 2016 Nov 29. Review.

3.

Role of elosulfase alfa in mucopolysaccharidosis IVA.

Regier DS, Tanpaiboon P.

Appl Clin Genet. 2016 Jun 14;9:67-74. doi: 10.2147/TACG.S69080. eCollection 2016. Review.

4.

Activity of daily living for Morquio A syndrome.

Yasuda E, Suzuki Y, Shimada T, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, Xie L, Miller F, Rahman T, Kecskemethy HH, Nagao K, Morlet T, Shaffer TH, Chinen Y, Yabe H, Tanaka A, Shintaku H, Orii KE, Orii KO, Mason RW, Montaño AM, Fukao T, Orii T, Tomatsu S.

Mol Genet Metab. 2016 Jun;118(2):111-22. doi: 10.1016/j.ymgme.2016.04.005. Epub 2016 Apr 25.

5.

Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.

Tomatsu S, Sawamoto K, Shimada T, Bober MB, Kubaski F, Yasuda E, Mason RW, Khan S, Alméciga-Díaz CJ, Barrera LA, Mackenzie WG, Orii T.

Expert Opin Orphan Drugs. 2015 Nov 1;3(11):1279-1290. Epub 2015 Oct 29.

6.

Hematopoietic stem cell transplantation for Morquio A syndrome.

Yabe H, Tanaka A, Chinen Y, Kato S, Sawamoto K, Yasuda E, Shintaku H, Suzuki Y, Orii T, Tomatsu S.

Mol Genet Metab. 2016 Feb;117(2):84-94. doi: 10.1016/j.ymgme.2015.09.011. Epub 2015 Oct 1.

7.

Obstructive airway in Morquio A syndrome, the past, the present and the future.

Tomatsu S, Averill LW, Sawamoto K, Mackenzie WG, Bober MB, Pizarro C, Goff CJ, Xie L, Orii T, Theroux M.

Mol Genet Metab. 2016 Feb;117(2):150-6. doi: 10.1016/j.ymgme.2015.09.007. Epub 2015 Sep 21.

8.

Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.

Tomatsu S, Sawamoto K, Alméciga-Díaz CJ, Shimada T, Bober MB, Chinen Y, Yabe H, Montaño AM, Giugliani R, Kubaski F, Yasuda E, Rodríguez-López A, Espejo-Mojica AJ, Sánchez OF, Mason RW, Barrera LA, Mackenzie WG, Orii T.

Drug Des Devel Ther. 2015 Apr 1;9:1937-53. doi: 10.2147/DDDT.S68562. eCollection 2015. Review.

9.

Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA.

Chinen Y, Higa T, Tomatsu S, Suzuki Y, Orii T, Hyakuna N.

Mol Genet Metab Rep. 2014;1:31-41.

10.

Therapies for the bone in mucopolysaccharidoses.

Tomatsu S, Alméciga-Díaz CJ, Montaño AM, Yabe H, Tanaka A, Dung VC, Giugliani R, Kubaski F, Mason RW, Yasuda E, Sawamoto K, Mackenzie W, Suzuki Y, Orii KE, Barrera LA, Sly WS, Orii T.

Mol Genet Metab. 2015 Feb;114(2):94-109. doi: 10.1016/j.ymgme.2014.12.001. Epub 2014 Dec 9. Review.

11.

Overcoming the barriers to diagnosis of Morquio A syndrome.

Bhattacharya K, Balasubramaniam S, Choy YS, Fietz M, Fu A, Jin DK, Kim OH, Kosuga M, Kwun YH, Inwood A, Lin HY, McGill J, Mendelsohn NJ, Okuyama T, Samion H, Tan A, Tanaka A, Thamkunanon V, Toh TH, Yang AD, Lin SP.

Orphanet J Rare Dis. 2014 Nov 30;9:192. doi: 10.1186/s13023-014-0192-7.

12.

Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).

Tomatsu S, Alméciga-Díaz CJ, Barbosa H, Montaño AM, Barrera LA, Shimada T, Yasuda E, Mackenzie WG, Mason RW, Suzuki Y, Orii KE, Orii T.

Expert Opin Orphan Drugs. 2013 Oct 1;1(10):805-818.

13.

International guidelines for the management and treatment of Morquio A syndrome.

Hendriksz CJ, Berger KI, Giugliani R, Harmatz P, Kampmann C, Mackenzie WG, Raiman J, Villarreal MS, Savarirayan R.

Am J Med Genet A. 2015 Jan;167A(1):11-25. doi: 10.1002/ajmg.a.36833. Epub 2014 Oct 24. Review.

14.

Paraplegia after epidural-general anesthesia in a Morquio patient with moderate thoracic spinal stenosis.

Drummond JC, Krane EJ, Tomatsu S, Theroux MC, Lee RR.

Can J Anaesth. 2015 Jan;62(1):45-9. doi: 10.1007/s12630-014-0247-1. Epub 2014 Oct 17.

15.

Orthopedic management of the extremities in patients with Morquio A syndrome.

White KK, Jester A, Bache CE, Harmatz PR, Shediac R, Thacker MM, Mackenzie WG.

J Child Orthop. 2014 Aug;8(4):295-304. doi: 10.1007/s11832-014-0601-4. Epub 2014 Jul 8.

16.

Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.

Tomatsu S, Mackenzie WG, Theroux MC, Mason RW, Thacker MM, Shaffer TH, Montaño AM, Rowan D, Sly W, Alméciga-Díaz CJ, Barrera LA, Chinen Y, Yasuda E, Ruhnke K, Suzuki Y, Orii T.

Res Rep Endocr Disord. 2012 Dec;2012(2):65-77.

17.

Evolving frontiers in severe polytrauma management - refining the essential principles.

Chak Wah K, Wai Man C, Janet Yuen Ha W, Lai V, Kit Shing John W.

Malays J Med Sci. 2013 Jan;20(1):1-12.

18.

Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.

Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, Gravance CG, Orii T, Tomatsu S.

Mol Genet Metab. 2013 Sep-Oct;110(1-2):54-64. doi: 10.1016/j.ymgme.2013.04.002. Epub 2013 Apr 10. Review.

19.

Current and emerging management options for patients with Morquio A syndrome.

Algahim MF, Almassi GH.

Ther Clin Risk Manag. 2013;9:45-53. doi: 10.2147/TCRM.S24771. Epub 2013 Feb 11.

20.

Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management.

Solanki GA, Martin KW, Theroux MC, Lampe C, White KK, Shediac R, Lampe CG, Beck M, Mackenzie WG, Hendriksz CJ, Harmatz PR.

J Inherit Metab Dis. 2013 Mar;36(2):339-55. doi: 10.1007/s10545-013-9586-2. Epub 2013 Feb 6. Review.

Supplemental Content

Support Center